Literature DB >> 11737002

Assessing patient preference in migraine treatment.

C Dahlöf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11737002     DOI： 10.1046/j.1468-2982.2001.218256.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN： 0333-1024            Impact factor:   6.292


× No keyword cloud information.
  11 in total

Review 1.  Almotriptan: a review of its use in migraine.

Authors:  Susan J Keam; Karen L Goa; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan.

Authors:  Fernando Iglesias Díez; Andreas Straube; Giorgio Zanchin
Journal:  J Neurol       Date:  2007-03-02       Impact factor: 4.849

Review 3.  [Clinical use of triptans in the management of migraine].

Authors:  Michel Lantéri-Minet
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study.

Authors:  Vincenzo Tullo; Gianni Allais; Michel D Ferrari; Marcella Curone; Eliana Mea; Stefano Omboni; Chiara Benedetto; Dario Zava; Gennaro Bussone
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

Review 5.  Newer formulations of the triptans: advances in migraine management.

Authors:  Jonathan Paul Gladstone; Marek Gawel
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.

Authors:  Lidia Savi; Stefano Omboni; Carlo Lisotto; Giorgio Zanchin; Michel D Ferrari; Dario Zava; Lorenzo Pinessi
Journal:  J Headache Pain       Date:  2010-08-05       Impact factor: 7.277

7.  A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine.

Authors:  Marco Bartolini; Maria Adele Giamberardino; Carlo Lisotto; Paolo Martelletti; Davide Moscato; Biagio Panascia; Lidia Savi; Luigi Alberto Pini; Grazia Sances; Patrizia Santoro; Giorgio Zanchin; Stefano Omboni; Michel D Ferrari; Filippo Brighina; Brigida Fierro
Journal:  J Headache Pain       Date:  2011-03-25       Impact factor: 7.277

8.  Osteoporosis medication profile preference: results from the PREFER-US study.

Authors:  Thomas W Weiss; Colleen A McHorney
Journal:  Health Expect       Date:  2007-09       Impact factor: 3.377

9.  Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.

Authors:  Hans-Christoph Diener; Cristina Tassorelli; David W Dodick; Stephen D Silberstein; Richard B Lipton; Messoud Ashina; Werner J Becker; Michel D Ferrari; Peter J Goadsby; Patricia Pozo-Rosich; Shuu-Jiun Wang; Jay Mandrekar
Journal:  Cephalalgia       Date:  2019-02-26       Impact factor: 6.292

10.  Investigating Patients' Preferences to Inform Drug Development Decisions: Novel Insights from a Discrete Choice Experiment in Migraine.

Authors:  Aleksandra Torbica; Carla Rognoni; Rosanna Tarricone
Journal:  Int J Environ Res Public Health       Date:  2021-05-05       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.